U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9408194081Blood Test for Ovarian Cancer Associated Auto AntibodiesRecruitingNo Results AvailableOvarian Cancerhttps://ClinicalTrials.gov/show/NCT01334437
9408294082Oxidative Stress in Robot-assisted Laparoscopic Radical ProstatectomyRecruitingNo Results AvailableOxidative StressDrug: propofolhttps://ClinicalTrials.gov/show/NCT01334424
9408394083Identifying Good and Poor Surgical Behaviour in the Danish Operating RoomCompletedNo Results AvailableSurgical Behaviour in the Operating Roomhttps://ClinicalTrials.gov/show/NCT01334411
9408494084A Health & Wellness Intervention for Individuals With Traumatic Brain Injury (TBI)CompletedNo Results AvailableTraumatic Brain InjuryBehavioral: Health & Wellnesshttps://ClinicalTrials.gov/show/NCT01334398
9408594085Operation Enduring Freedom/Operation Iraqi Freedom Veterans' Experiences of Habituation to Pain, Perceived Burdensomeness, and Failed BelongingnessCompletedNo Results AvailableSuicidehttps://ClinicalTrials.gov/show/NCT01334385
9408694086Intensive Outpatient Treatment for Suicidal VeteransCompletedNo Results AvailableSuicidalityBehavioral: CAMShttps://ClinicalTrials.gov/show/NCT01334372
9408794087Exercise Effects on Cognition in School-Aged ChildrenCompletedNo Results AvailableBrain Health|Cognition|Scholastic AchievementBehavioral: Physical Activityhttps://ClinicalTrials.gov/show/NCT01334359
9408894088Footwear Minimalism StudyCompletedNo Results AvailableHealthy RunnersOther: Nike Pegasus|Other: Nike Free 3.0|Other: Vibram Five Fingers Shoehttps://ClinicalTrials.gov/show/NCT01334346
9408994089Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant RecipientsRecruitingNo Results AvailableRenal Disease|Renal TransplantDrug: Tacrolimus - Prograf® twice daily formulation|Drug: Tacrolimus - Advagraf® once daily formulationhttps://ClinicalTrials.gov/show/NCT01334333
9409094090Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell CarcinomaRecruitingNo Results AvailableOral Squamous Cell CarcinomaProcedure: elective neck dissectionhttps://ClinicalTrials.gov/show/NCT01334320
9409194091Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)CompletedNo Results AvailableEmphysemaDevice: Lung Volume Reduction Coil (LVRC) (PneumRx)|Device: Controlhttps://ClinicalTrials.gov/show/NCT01334307
9409294092Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular DegenerationCompletedNo Results AvailableAge Related Macular Degeneration|Choroidal NeovascularizationDevice: ForeseeHomehttps://ClinicalTrials.gov/show/NCT01334294
9409394093An In-vitro Standardization of B Cell Elispot AssaysTerminatedNo Results AvailableTransplant Sensitization|Panel Reactive Antibody|Sensitization to HLA AntigensProcedure: Blood Draw|Procedure: Blood Drawhttps://ClinicalTrials.gov/show/NCT01334281
9409494094Resolute Zotarolimus-Eluting Stent Versus the Taxus Liberte Paclitaxel-Eluting Stent for Percutaneous Coronary Intervention in ChinaActive, not recruitingNo Results AvailableIschemic Heart Disease|Stenotic Coronary Lesion|Cardiovascular Diseases|Arteriosclerosis|Coronary Artery DiseaseDevice: Taxus Liberte Paclitaxel-Eluting Coronary Stent System|Device: Resolute Zotarolimus-Eluting Coronary Stent Systemhttps://ClinicalTrials.gov/show/NCT01334268
9409594095iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)TerminatedNo Results AvailablePigment Epithelial DetachmentDrug: iSONEP (sonepcizumab/LT1009)https://ClinicalTrials.gov/show/NCT01334255
9409694096A Study to Determine the Pharmacodynamics of LX4211 Relative to Meals in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: Schedule A|Drug: Schedule B|Drug: Schedule C|Drug: Schedule D|Drug: Schedule Ehttps://ClinicalTrials.gov/show/NCT01334242
9409794097Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 DiabetesCompletedHas ResultsType 2 Diabetes MellitusDrug: Sitagliptin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01334229
9409894098Using Computers to Assist in Parental Smoking Cessation in a Pediatric SettingCompletedNo Results AvailableCigarette SmokingOther: CHICA Smoking Cessation Module|Other: CHICA Placebohttps://ClinicalTrials.gov/show/NCT01334216
9409994099A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)WithdrawnNo Results AvailableAngina Pectoris|Coronary Artery Disease|Type 2 Diabetes MellitusDrug: Ranolazinehttps://ClinicalTrials.gov/show/NCT01334203
9410094100A Prospective Observational Study of the Performance of Zarin in KenyaCompletedNo Results AvailableContraceptive Usagehttps://ClinicalTrials.gov/show/NCT01334190
9410194101TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNo Results AvailableMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell CarcinomDrug: TLR8 agonist VTX-2337|Biological: cetuximab|Other: laboratory biomarker analysis|Other: pharmacogenomic studieshttps://ClinicalTrials.gov/show/NCT01334177
9410294102Recovery Management Checkups for Women OffendersCompletedNo Results AvailableRecovery Management Checkup (RMC)|Outcome MonitoringBehavioral: Recovery Management Checkups|Other: Outcome Monitoringhttps://ClinicalTrials.gov/show/NCT01334164
9410394103Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 DiabetesCompletedNo Results AvailableDiabetes Mellitus Type 1Drug: Insulin LISPRO|Drug: recombinant human insulinhttps://ClinicalTrials.gov/show/NCT01334151
9410494104Effect of Dietary Sodium Intake on Blood Pressure in Hypertensive Patients in Primary CareCompletedNo Results AvailableArterial HypertensionOther: A 4-week diet, low in sodium.https://ClinicalTrials.gov/show/NCT01334138
9410594105Adjunctive Metformin Therapy in Double DiabetesCompletedNo Results AvailableDiabetes MellitusDrug: Metformin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01334125
9410694106Study of Axitinib in Patients With Unresectable Hepatocellular CarcinomaActive, not recruitingNo Results AvailableHepatocellular CarcinomaDrug: Axitinib (AG-013736)https://ClinicalTrials.gov/show/NCT01334112
9410794107Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer PatientsTerminatedNo Results AvailableMetastatic Breast CancerBiological: CP-675,206|Radiation: External local radiation therapyhttps://ClinicalTrials.gov/show/NCT01334099
9410894108Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction ChemotherapyCompletedNo Results AvailableAcute Myeloid LeukemiaDrug: Aprepitanthttps://ClinicalTrials.gov/show/NCT01334086
9410994109Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsCompletedNo Results AvailableMalignant Advanced Solid Tumors|Carcinoma, Renal CellDrug: Axitinib plus everolimushttps://ClinicalTrials.gov/show/NCT01334073
9411094110WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular ElectroporationSuspendedNo Results AvailableLeukaemia (Acute)|Leukaemia (Chronic)|Leukaemia (Acute Myeloid)|Leukaemia (Acute Lymphoblastic)|Leukaemia (Acute Promyelocytic)Biological: p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccinehttps://ClinicalTrials.gov/show/NCT01334060

* Görseller ve İçerik tekif hakkına sahip olabilir